• summary
• income statement
• balance sheet
• cash flow
• other data

Get all company financials in excel:

Download Sample   $19.99

More Charts

Finance

Uxin has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of CNY -2,486 mil in 2018, or -75.0% of sales. That’s compared to -104% average margin seen in last five years.

The company netted CNY -1,523 mil in 2018 implying ROE of -117% and ROCE of -152%. Again, the average figures were -493% and -256%, respectively when looking at the previous 5 years.

Uxin’s net debt amounted to CNY 305 mil at the end of 2018, or 0.129 of equity. When compared to EBITDA, net debt was -0.123x, down when compared to average of -0.102x seen in the last 5 years.

Valuation

Uxin stock traded at CNY 33.4 per share at the end of 2018 resulting in a market capitalization of USD 2,322 mil. Over the previous five years, stock price grew by 0% or % a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of -6.37x and price to earnings (PE) of -10.5x as of 2018.